No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MRVI Maravai LifeSciences
- 8.970
- +0.170+1.93%
Close May 3 16:00 ET
- 8.995
- +0.025+0.28%
Post 17:30 ET
1.19BMarket Cap-9966P/E (TTM)
9.135High8.850Low1.81MVolume8.960Open8.800Pre Close16.25MTurnover1.84%Turnover RatioLossP/E (Static)132.65MShares16.62052wk High2.85P/B883.31MFloat Cap4.52052wk Low--Dividend TTM98.47MShs Float63.550Historical High--Div YieldTTM3.24%Amplitude4.520Historical Low8.985Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Craig-Hallum Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI)
TriLink BioTechnologies And Lonza Enter Into Non-exclusive License And Supply Agreement For CleanCap MRNA Capping Technology
TriLink BioTechnologies And Lonza Enter Into Non-exclusive License And Supply Agreement For CleanCap MRNA Capping Technology
Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego
Maravai LifeSciences Holdings' (MRVI) TriLink BioTechnologies unit said Thursday that it has opened its new, 32,000-square-foot cGMP mRNA manufacturing facility in San Diego. The facility will use Tri
Analysts Offer Insights on Healthcare Companies: Diamedica Therapeutics (DMAC), Inspire Medical Systems (INSP) and Maravai Lifesciences Holdings (MRVI)
Trilink Biotechnologies, A Maravai Lifesciences Company Opened A New 32,000 Sq.ft. MRNA Manufacturing Facility
Trilink Biotechnologies, A Maravai Lifesciences Company Opened A New 32,000 Sq.ft. MRNA Manufacturing Facility
HROW, HCAT and EGRX Are Among After Hour Movers
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg